1. Human CST Facilitates Genome-wide RAD51 Recruitment to GC-Rich Repetitive Sequences in Response to Replication Stress
   Megan Chastain et al, 2016, Cell Reports CrossRef
2. A First-In-Class, Humanized Antibody Targeting Alternatively Spliced Tissue Factor: Preclinical Evaluation in an Orthotopic Model of Pancreatic Ductal Adenocarcinoma
   Clayton S. Lewis et al, 2021, Frontiers in Oncology CrossRef
3. Evaluation of two in vitro assays for tumorigenicity assessment of CRISPR-Cas9 genome-edited cells
   Myriam Lemmens et al, 2021, Molecular Therapy - Methods & Clinical Development CrossRef
4. Cell-Penetrating CEBPB and CEBPD Leucine Zipper Decoys as Broadly Acting Anti-Cancer Agents
   Qing Zhou et al, 2021, Cancers CrossRef
5. Role of Rad51 and DNA repair in cancer: A molecular perspective
   Erik Laurini et al, 2020, Pharmacology & Therapeutics CrossRef
6. Non-clinical safety assessment of novel drug modalities: Genome safety perspectives on viral-, nuclease- and nucleotide-based gene therapies
   Myriam Lemmens et al, 2024, Mutation Research - Genetic Toxicology and Environmental Mutagenesis CrossRef
7. A Localized Chimeric Hydrogel Therapy Combats Tumor Progression through Alteration of Sphingolipid Metabolism
   Sanjay Pal et al, 2019, ACS Central Science CrossRef
8. Human CST complex restricts excessive PrimPol repriming upon UV induced replication stress by suppressing p21
   Pau Biak Sang et al, 2024, Nucleic Acids Research CrossRef
9. CST in maintaining genome stability: Beyond telomeres
   Xinxing Lyu et al, 2021, DNA Repair CrossRef
10. The CST complex facilitates cell survival under oxidative genotoxic stress
    Tomohiko Hara et al, 2023, PLOS ONE CrossRef
11. Non-Steroidal Anti-Inflammatory Drugs Increase Cisplatin, Paclitaxel, and Doxorubicin Efficacy against Human Cervix Cancer Cells
    Diana Xochiquetzal Robledo-Cadena et al, 2020, Pharmaceuticals CrossRef